Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill

Executive Summary

Merck wants dual-eligible seniors to be covered by the new Medicare Rx benefit to ensure that they are protected by formulary practice standards included in the bill

You may also be interested in...



Merck Looks Past Medicare: Next Up, Covering The Uninsured

Merck is preparing for what it believes should be the next big health care policy debate in Washington after Medicare Rx legislation is enacted: health care coverage for the uninsured

Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow

Pfizer expects to see a "significant" increase in prescription utilization by seniors once Medicare drug coverage is enacted, CEO Henry McKinnell told securities analysts in New York City June 17

Medicare Rx Card: Will Drug Discounts Be Permanent Program Fixture?

The role of a Medicare prescription drug discount card will be worked out between the House Energy & Commerce and Ways & Means Committees before a single Medicare bill comes to the floor for a vote

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel